Home » About Us » Board of management » Zvonko Bogdanovski

Zvonko Bogdanovski, Member of the Board of Management

Zvonko graduated from the Faculty of Pharmacy in Ljubljana in 1983 and began his career in Lek as a researcher, analyst and research technologist, after which he spent the majority of his career in pharmaceutical marketing and sales management. He holds an MBA from IEDC Business School at Bled, Slovenia.

After assuming his first position in research and development 25 years ago, he became deputy head of the Lek foreign trade department in 1990, and was appointed head of pharmaceuticals sales in Central and Eastern Europe in 1993, in the period when Lek began to intensify marketing and sales of its products outside Slovenia. In this interesting and dynamic period through 1999, when he became head of pharmaceuticals sales, he and his colleagues developed the sales network that today still forms the basis of Sandoz sales in Central and Eastern Europe and the CIS.

Following the Novartis acquisition of Lek, and subsequently Hexal, he was deeply involved in the integration process, and succeeded together with his team in leading Sandoz to a market leading position in the markets he headed. In the cluster CEE I, for which he was responsible until the end of 2008, he further strengthened the leading Sandoz position.

In 2009, he became Country Head Slovenia as part of a wider structural reorganization within Sandoz, following which he is also responsible for the South Eastern Europe country grouping (Albania, Bosnia & Herzegovina, Croatia, Kosovo, Macedonia, Montenegro, Serbia and Slovenia).

Zvonko Bogdanovski was appointed a member of the Lek Board of Management for commercial operations February 9, 2009.